Biora Therapeutics Home
Activate the mobile navigation

Publications

Evaluation of the pharmacokinetics of glucagon-like-peptide-1 (GLP-1) receptor agonist delivered through the BioJet™ oral biotherapeutic delivery platform in a porcine model
#Systemic Therapeutics
Potential effects of food on a novel Drug Delivery System (DDS) to deliver therapeutic compound into the colon
#Targeted Therapeutics
Development of a novel Drug Delivery System (DDS) to deliver drugs directly to the colonic mucosa to improve efficacy and reduce systemic exposure for the treatment of ulcerative colitis (UC)
#Targeted Therapeutics
A scintigraphic study to evaluate the localization and delivery function of a Drug Delivery System (DDS) device in patients with active ulcerative colitis in fasted state
#Targeted Therapeutics
A scintigraphic study to evaluate the safety, tolerability, and functionality of a Drug Delivery System (DDS) device in healthy volunteers in fasted state
#Targeted Therapeutics
Pilot study to assess pharmacokinetic and pharmacodynamic markers following enema-dosing with adalimumab in patients with active ulcerative colitis
#Targeted Therapeutics
Evaluation of the pharmacokinetics of PGN-OB1 following oral administration of an oral biotherapeutics delivery system (OBDS) in Yucatan swine
#Systemic Therapeutics
Development of ex-vivo and in-vivo models to assess the performance of an oral biotherapeutic delivery system (OBDS) capsule
#Systemic Therapeutics
Development of preclinical models to assess the performance of the oral biotherapeutic delivery system (OBDS) capsule
#Systemic Therapeutics